Envisagenics, Inc

Envisagenics developed a bioinformatics software at CSHL to discover new therapies of RNA splicing for cancer and genetic disorders using biomedical big data

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location New York, NY, US
  • Currency USD
  • Founded April 2014
  • Employees 3
  • Incorporation Type C-corp
  • Website envisagenics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free